Pharma small-cap inventory Sigachi Industries noticed its shares soar virtually 17 % in intra-day commerce on Thursday, September 11, forward of the corporate’s document date for dividend payout. The Hyderabad-based producer of microcrystalline cellulose fastened September 16, 2025, because the document date for its dividend, as per an trade submitting dated September 4.
“As regards to the topic cited, that is to tell the Exchanges that Firm has fastened September 16, 2025 as document date for the aim of Dividend for the Monetary yr ended March 31, 2025,” it had introduced in an trade submitting on September 4.
In its annual common assembly (AGM) report on September 1, the board of administrators beneficial a dividend of 10 % — translating to ₹0.10 per fairness share — on the corporate’s paid-up fairness share capital for FY24-25. The full dividend outgo is anticipated to be ₹3.82 crore, for which provisions have already been made within the firm’s accounts.
Sigachi Industries Q1 Outcomes
For the primary quarter of FY26, Sigachi Industries reported an 11 % drop in consolidated web revenue to ₹13.26 crore, in comparison with ₹15.03 crore in the identical quarter final yr. Regardless of the revenue dip, income from operations surged 23 % year-on-year to ₹128.2 crore, as in opposition to ₹104.1 crore within the corresponding interval final yr.
The corporate attributed the rise in bills — which elevated to ₹107.7 crore from ₹94.1 crore a yr in the past — as one of many components impacting profitability.
Sigachi Industries Inventory Value Efficiency
Sigachi Industries’ shares rallied sharply, hitting a day’s excessive of ₹36.83, up 16.7 %. Regardless of Thursday’s surge, the smallcap inventory has shed over 43 % within the final one yr and is down 35 % during the last three months.
Nevertheless, the inventory has begun to recuperate in September, including over 17.5 % up to now this month after steep declines of 18 % in August, 22.5 % in July, and seven.7 % in June.
About Sigachi Industries
Sigachi Industries is a number one producer of cellulose-based excipients utilized in pharmaceutical formulations. The corporate additionally caters to the nutraceutical and meals ingredient industries. Its place as a home trade chief in microcrystalline cellulose makes it a key participant within the pharma provide chain.
Disclaimer: The views and proposals made above are these of particular person analysts or broking firms, and never of Mint. We advise traders to test with licensed consultants earlier than making any funding choices.
